A Roadmap to the REMS Program for Belantamab Mafodotin: A Treatment for Relapsed/Refractory Multiple Myeloma

By DocWire News Editors - Last Updated: April 28, 2023

MarkAlain Déry, DO, MPH, FACOIInfectious Disease | May 16, 2025

Why vaccine hesitancy is rising—and what we can do to counter it with facts, trust, and access.

MarkAlain Déry, DO, MPH, FACOINeurodivergent | May 8, 2025

1 in 31 U.S. kids are diagnosed with autism—what’s behind the rise? Noise Filter breaks it down, myths and all.

Pranav Garimella, MBBS, MPHNephrology Times | May 7, 2025

Dr. Pranav Garimella, CMO of the American Kidney Fund, discussed AMKD awareness and the importance of APOL1 gene variants.

MarkAlain Déry, DO, MPH, FACOIInfectious Disease | May 5, 2025

The NoiseFilter team expresses deep concern over policy changes to vaccine strategy following RFK Jr's appointment.

Joel Topf spoke with Mini Michael about the ILLUMINATE-B study of lumasiran for PH1 in infants and young children.

Related Posts